loadpatents
name:-0.071475982666016
name:-0.057626008987427
name:-0.016841888427734
Khan; M. Amin Patent Filings

Khan; M. Amin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Khan; M. Amin.The latest application filed is for "spiro-lactam nmda receptor modulators and uses thereof".

Company Profile
15.57.67
  • Khan; M. Amin - Evanston IL
  • Khan; M. Amin - Morgan Hill CA
  • Khan; M. Amin - Saskatoon CA
  • Khan, M. Amin - Carmel IN
  • Khan; M. Amin - Downingtown PA
  • Khan; M. Amin - Dowington PA
  • Khan; M. Amin - Downington PA
  • Khan; M. Amin - Dowingtown PA
  • Khan; M. Amin - Burlington MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Spiro-lactam NMDA modulators and methods of using same
Grant 11,427,585 - Khan August 30, 2
2022-08-30
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20220220119 - Khan; M. Amin
2022-07-14
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 11,376,250 - Khan July 5, 2
2022-07-05
Spiro-lactam NMDA modulators and methods of using same
Grant 11,370,790 - Khan June 28, 2
2022-06-28
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20220151992 - Lowe, III; John A. ;   et al.
2022-05-19
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 11,299,495 - Khan April 12, 2
2022-04-12
Spiro-lactam And Bis-spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20220098211 - Khan; M. Amin
2022-03-31
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20220002242 - Khan; M. Amin
2022-01-06
Nmda Receptor Modulators And Uses Thereof
App 20210332061 - Khan; M. Amin ;   et al.
2021-10-28
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20210322406 - Khan; M. Amin
2021-10-21
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 11,077,094 - Lowe, III , et al. August 3, 2
2021-08-03
Process For Synthesis Of Peptide Compounds
App 20210198315 - KHAN; M. Amin
2021-07-01
Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof
Grant 11,028,095 - Khan June 8, 2
2021-06-08
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20210155632 - Lowe, III; John A. ;   et al.
2021-05-27
Methods Of Treating Painful Diabetic Peripheral Neuropathy
App 20210139489 - Madsen; Torsten M. ;   et al.
2021-05-13
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,961,189 - Khan March 30, 2
2021-03-30
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20210047324 - Khan; M. Amin
2021-02-18
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,918,637 - Khan February 16, 2
2021-02-16
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20210040095 - Khan; M. Amin
2021-02-11
NMDA receptor modulators and uses thereof
Grant 10,906,913 - Khan , et al. February 2, 2
2021-02-02
Spiro-lactam Nmda Modulators And Methods Of Using Same
App 20210002279 - Khan; M. Amin
2021-01-07
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20200206189 - Lowe, III; John A. ;   et al.
2020-07-02
Spiro-lactam And Bis-spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20200181159 - Khan; M. Amin
2020-06-11
Spiro-lactam Nmda Modulators And Methods Of Using Same
App 20190330209 - Khan; M. Amin
2019-10-31
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,441,571 - Lowe, III , et al. Oc
2019-10-15
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,441,572 - Lowe, III , et al. Oc
2019-10-15
Spiro-lactam Nmda Modulators And Methods Of Using Same
App 20190194200 - KHAN; M. Amin
2019-06-27
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20190175588 - Khan; M. Amin
2019-06-13
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20190177334 - Khan; M. Amin
2019-06-13
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,316,041 - Lowe, III , et al.
2019-06-11
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20190161442 - Khan; M. Amin
2019-05-30
Ndma Receptor Modulators And Uses Thereof
App 20190135862 - Khan; M. Amin ;   et al.
2019-05-09
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,273,239 - Lowe, III , et al.
2019-04-30
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,253,032 - Lowe, III , et al.
2019-04-09
Nmda Receptor Modulators And Uses Thereof
App 20190077807 - Khan; M. Amin ;   et al.
2019-03-14
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,195,179 - Khan Fe
2019-02-05
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,196,401 - Khan Fe
2019-02-05
Spiro-lactam NMDA modulators and methods of using same
Grant 10,150,769 - Khan Dec
2018-12-11
Spiro-lactam Nmda Modulators And Methods Of Using Same
App 20180291023 - Khan; M. Amin
2018-10-11
N-methyl-d-aspartate Receptor Modulators And Methods Of Making And Using Same
App 20180258139 - Khan; M. Amin
2018-09-13
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180250268 - Lowe, III; John A. ;   et al.
2018-09-06
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180250267 - Lowe, III; John A. ;   et al.
2018-09-06
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180244680 - Lowe, III; John A. ;   et al.
2018-08-30
Nmda Receptor Modulators And Uses Thereof
App 20180237474 - Moskal; Joseph ;   et al.
2018-08-23
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 10,052,308 - Lowe, III , et al. August 21, 2
2018-08-21
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180215767 - Lowe, III; John A. ;   et al.
2018-08-02
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180179217 - Lowe, III; John A. ;   et al.
2018-06-28
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180179218 - Lowe, III; John A. ;   et al.
2018-06-28
N-methyl-D-aspartate receptor modulators and methods of making and using same
Grant 9,994,614 - Khan June 12, 2
2018-06-12
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180155354 - Lowe, III; John A. ;   et al.
2018-06-07
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180093994 - Khan; M. Amin
2018-04-05
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20180092879 - Khan; M. Amin
2018-04-05
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,932,347 - Khan April 3, 2
2018-04-03
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,925,169 - Khan March 27, 2
2018-03-27
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,828,384 - Lowe, III , et al. November 28, 2
2017-11-28
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20170333395 - Khan; M. Amin
2017-11-23
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20170334922 - Khan; M. Amin
2017-11-23
NMDA receptor modulators and uses thereof
Grant 9,802,946 - Khan , et al. October 31, 2
2017-10-31
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,758,525 - Lowe, III , et al. September 12, 2
2017-09-12
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,738,650 - Lowe, III , et al. August 22, 2
2017-08-22
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20170231956 - Lowe, III; John A. ;   et al.
2017-08-17
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,708,335 - Lowe, III , et al. July 18, 2
2017-07-18
Secondary structure stabilized NMDA receptor modulators and uses thereof
Grant 9,593,145 - Moskal , et al. March 14, 2
2017-03-14
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,579,304 - Lowe, III , et al. February 28, 2
2017-02-28
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20160368926 - Lowe, III; John A. ;   et al.
2016-12-22
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,512,134 - Lowe, III , et al. December 6, 2
2016-12-06
NMDA receptor modulators and uses thereof
Grant 9,512,133 - Khan , et al. December 6, 2
2016-12-06
Spiro-lactam NMDA receptor modulators and uses thereof
Grant 9,504,670 - Lowe, III , et al. November 29, 2
2016-11-29
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20160289240 - Lowe, III; John A. ;   et al.
2016-10-06
Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
Grant 9,334,235 - Khan , et al. May 10, 2
2016-05-10
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20160122359 - Lowe, III; John A. ;   et al.
2016-05-05
Secondary Structure Stabilized Nmda Receptor Modulators And Uses Thereof
App 20160115197 - Moskal; Joseph R. ;   et al.
2016-04-28
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20150376195 - Lowe, III; John A. ;   et al.
2015-12-31
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20150368253 - Lowe, III; John A. ;   et al.
2015-12-24
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20150368252 - Lowe, III; John A. ;   et al.
2015-12-24
Spiro-lactam Nmda Receptor Modulators And Uses Thereof
App 20150368254 - Lowe, III; John A. ;   et al.
2015-12-24
NMDA Receptor Modulators and Uses Thereof
App 20150336969 - Khan; M. Amin ;   et al.
2015-11-26
NMDA Receptor Modulators and Uses Thereof
App 20150315237 - Moskal; Joseph R. ;   et al.
2015-11-05
Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof
Grant 9,169,280 - Khan , et al. October 27, 2
2015-10-27
Secondary structure stabilized NMDA receptor modulators and uses thereof
Grant 9,101,612 - Moskal , et al. August 11, 2
2015-08-11
Methods for the synthesis of 13C labeled iodotridecane and use as a reference standard
Grant 9,012,704 - Khan , et al. April 21, 2
2015-04-21
NMDA Receptor Modulators and Uses Thereof
App 20150105364 - Khan; M. Amin ;   et al.
2015-04-16
Methods for the synthesis of 13C labeled plasmalogen
Grant 9,006,472 - Khan , et al. April 14, 2
2015-04-14
Nmda Receptor Modulators And Uses Thereof
App 20150051262 - Khan; M. Amin ;   et al.
2015-02-19
Methods For The Synthesis Of 13c Labeled Dha And Use As A Reference Standard
App 20140336397 - Khan; M. Amin ;   et al.
2014-11-13
Methods For The Synthesis Of 13c Labeled Plasmalogen
App 20140323749 - Khan; M. Amin ;   et al.
2014-10-30
Methods For The Synthesis Of 13c Labeled Iodotridecane And Use As A Reference Standard
App 20140309464 - Khan; M. Amin ;   et al.
2014-10-16
Methods For The Synthesis Of Plasmalogens And Plasmalogen Derivatives, And Therapeutic Uses Thereof
App 20140296187 - Khan; M. Amin ;   et al.
2014-10-02
NMDA receptors modulators and uses thereof
Grant 8,673,843 - Moskal , et al. March 18, 2
2014-03-18
Secondary Structure Stabilized NMDA Receptor Modulators and Uses Thereof
App 20130053325 - Moskal; Joseph ;   et al.
2013-02-28
NMDA Receptors Modulators and Uses Thereof
App 20130035292 - Moskal; Joseph ;   et al.
2013-02-07
Hydroxy Fatty Acid Compounds And Uses Thereof For Disease Treatment And Diagnosis
App 20120136057 - Ritchie; Shawn ;   et al.
2012-05-31
Plasmalogen Compounds, Pharmaceutical Compositions Containing The Same And Methods For Treating Diseases Of The Aging
App 20120035250 - Khan; M. Amin ;   et al.
2012-02-09
Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
Grant 7,115,666 - Khan , et al. October 3, 2
2006-10-03
Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
App 20060100289 - Khan; M. Amin ;   et al.
2006-05-11
Use of aryl nitrone compounds in methods for treating neuropathic pain
Grant 6,835,754 - Waterbury , et al. December 28, 2
2004-12-28
Modulated release from biocompatible polymers
App 20040241230 - Bernstein, Howard ;   et al.
2004-12-02
Use of aryl nitrone compounds in methods for treating neuropathic pain
App 20040209958 - Waterbury, L. David ;   et al.
2004-10-21
Controlled release of metal cation-stabilized interferon
Grant 6,780,434 - Tracy , et al. August 24, 2
2004-08-24
Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
App 20040142983 - Khan, M. Amin ;   et al.
2004-07-22
Modulated release from biocompatible polymers
Grant 6,749,866 - Bernstein , et al. June 15, 2
2004-06-15
Composition for sustained release of human growth hormone
App 20030211153 - Johnson, Olufunmi Lily ;   et al.
2003-11-13
Device for the sustained release of aggregation-stabilized, biologically active agent
App 20030133979 - Burke, Paul A. ;   et al.
2003-07-17
Controlled release of metal cation-stabilized interferon
App 20030031716 - Tracy, Mark A. ;   et al.
2003-02-13
Device for the sustained release of aggregation-stabilized, biologically active agent
Grant 6,514,533 - Burke , et al. February 4, 2
2003-02-04
Composition for sustained release of human growth hormone
Grant 6,500,448 - Johnson , et al. December 31, 2
2002-12-31
Modulated release from biocompatible polymers
App 20020168410 - Bernstein, Howard ;   et al.
2002-11-14
Use of aryl nitrone compounds in methods for treating neuropathic pain
App 20020165274 - Waterbury, L. David ;   et al.
2002-11-07
Controlled release of metal cation-stabilized interferon
Grant 6,379,701 - Tracy , et al. April 30, 2
2002-04-30
Modulated release from biocompatible polymers
Grant 6,368,630 - Bernstein , et al. April 9, 2
2002-04-09
Controlled release of metal cation-stabilized interferon
Grant 6,165,508 - Tracy , et al. December 26, 2
2000-12-26
Composition for sustained release of human growth hormone
Grant 6,051,259 - Johnson , et al. April 18, 2
2000-04-18
Modulated release from biocompatible polymers
Grant 5,912,015 - Bernstein , et al. June 15, 1
1999-06-15
Composition for sustained release of human growth hormone
Grant 5,891,478 - Johnson , et al. April 6, 1
1999-04-06
Composition and method for the controlled release of metal cation-stabilized interferon
Grant 5,711,968 - Tracy , et al. January 27, 1
1998-01-27
Composition for sustained release of human growth hormone
Grant 5,667,808 - Johnson , et al. September 16, 1
1997-09-16
Modulated release from biocompatible polymers
Grant 5,656,297 - Bernstein , et al. * August 12, 1
1997-08-12
Composition for sustained release of human growth hormone
Grant 5,654,010 - Johnson , et al. August 5, 1
1997-08-05
Controlled release ACTH containing microspheres
Grant 5,413,797 - Khan , et al. May 9, 1
1995-05-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed